Literature DB >> 20400800

A 3-year clinical and radiographic study of implants placed simultaneously with maxillary sinus floor augmentations using a new nanocrystalline hydroxyapatite.

F Heinemann1, T Mundt, R Biffar, T Gedrange, W Goetz.   

Abstract

The aims of this case series was to evaluate the success rate of implants and their restorations, the sinus bone graft resorption, and the marginal bone loss around the implants when nanocristalline HA embedded in a silica matrix was exclusively used as grafting material. In 13 partially edentulous patients of a private practice having missing teeth in the posterior maxilla and a subantral bone height between 3 and 7 mm, 19 sinus augmentations (100% Nanobone, Artoss, Rostock, Germany) by the lateral lift technique were performed. The implants (Tiolox/Tiologic Implants, Dentaurum, Ispringen, Germany) were simultaneously placed. After 6 to 9 months 37 implants were restored with fixed dental prostheses. The clinical evaluation included peri-implant parameters, periotest measurements and the restorations. The radiographic bone heights over time were estimated with linear mixed models. The implant success rate was 100% after three years. The periotest values (between -7 and -6) after implant abutment connection indicated a solid osseointegration. The mean rates of the marginal bone loss over the first year were higher (mesial: -0.55, distal: -0.51 mm) than the annual rates thereafter (mesial: -0.09 mm, distal: -0.08 mm). The mean rates of changes in the total bone height were neglectable (<0.2 mm) and not significant. The prosthodontic and esthetic evaluation revealed a successful outcome. Within the limits of this clinical report it may be concluded that maxillary sinus augmentation using 100% nanocristalline HA embedded in a silica matrix to support implants is a reliable procedure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20400800

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  7 in total

1.  Evaluation of injectable silica-embedded nanohydroxyapatite bone substitute in a rat tibia defect model.

Authors:  Weiguo Xu; Cornelia Ganz; Ulf Weber; Martin Adam; Gerd Holzhüter; Daniel Wolter; Bernhard Frerich; Brigitte Vollmar; Thomas Gerber
Journal:  Int J Nanomedicine       Date:  2011-08-02

2.  Autologous serum improves bone formation in a primary stable silica-embedded nanohydroxyapatite bone substitute in combination with mesenchymal stem cells and rhBMP-2 in the sheep model.

Authors:  Anja M Boos; Annika Weigand; Gloria Deschler; Thomas Gerber; Andreas Arkudas; Ulrich Kneser; Raymund E Horch; Justus P Beier
Journal:  Int J Nanomedicine       Date:  2014-11-19

3.  Biomechanics and load resistance of short dental implants: a review of the literature.

Authors:  Istabrak Hasan; Christoph Bourauel; Torsten Mundt; Friedhelm Heinemann
Journal:  ISRN Dent       Date:  2013-05-08

4.  Schneider membrane elevation in presence of sinus septa: anatomic features and surgical management.

Authors:  Mario Beretta; Marco Cicciù; Ennio Bramanti; Carlo Maiorana
Journal:  Int J Dent       Date:  2012-07-17

5.  Subantral Augmentation with a 1/1 Alloplastic and Autologous Material Mixture. Histological Characteristics and Dimensional Stability of the Newly Formed Bone.

Authors:  Florin OniȘor-Gligor; Mihai Juncar; Grigore BăciuȚ; Simion Bran; Raluca-Iulia Juncar; Dinu-Iuliu DumitraȘcu; Mihaela-Felicia BăciuȚ
Journal:  Clujul Med       Date:  2015-01-28

6.  The Influence of the Crown-Implant Ratio on the Crestal Bone Level and Implant Secondary Stability: 36-Month Clinical Study.

Authors:  Jakub Hadzik; Maciej Krawiec; Konstanty Sławecki; Christiane Kunert-Keil; Marzena Dominiak; Tomasz Gedrange
Journal:  Biomed Res Int       Date:  2018-05-16       Impact factor: 3.411

7.  Short Implants and Conventional Implants in The Residual Maxillary Alveolar Ridge: A 36-Month Follow-Up Observation.

Authors:  Jakub Hadzik; Maciej Krawiec; Paweł Kubasiewicz-Ross; Agata Prylińska-Czyżewska; Tomasz Gedrange; Marzena Dominiak
Journal:  Med Sci Monit       Date:  2018-08-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.